The overall aim of our group's work is to investigate the molecular mechanisms regulating erythroid cell-specific gene expression during erythroid cell differentiation. We have been successful in cloning two non-globin genes of interest: the first encodes the rabbit red cell-specific lipoxygenase (LO X ), which has a role in degrading mitochondrial lipids during maturation of the reticulocyte to the erythrocyte; and the second, mouse glutathione peroxidase (G SH P X ), an important seleno-enzyme responsible for protection against peroxide-damage. Characterization of the G SH P X gene revealed that the seleno-cysteine residue in the active site of the enzyme is encoded by UGA, which usually functions as a translation-termination codon. This novel finding has important implications regarding the role of mRNA sequence context effects in codon recognition.
Introduction
Understanding how development is regulated revolves round three major questions (see Harrison (1988) for a recent general review of the subject): how cell proliferation is controlled to maintain homeostasis; how cell differentiation is regulated; and finally how spatial organization is established. Haematopoiesis (and erythropoiesis in particular) provides a useful experimental system in which to explore such questions at the molecular level and in particular the inter-relationship between cell growth and differentiation. proteins (the a-and /3-spectrins, ankyrin and band 4.1); the transmembrane sialoglycoproteins (glycophorins) and major anion exchange protein (band 3); the globins; the haem pathway enzymes (particularly porphobilinogen (PBG)-deaminase and uroporphyrinogen decarboxylase, both of which are elevated in red blood cells (RBCs)); and other families of enzymes of which particular isozymes are exclusive to red cells (the RBC lipoxygenase, carbonic anhydrase I and bisphosphoglycerate mutase) or are greatly elevated in RBCs (glutathione peroxidase (G SH PX )) (reviewed by Harrison, 1984) . The aim of our work over the past few years has been to try to elucidate some of the control mechanisms responsible for activating the expression of this set of genes during erythroid cell differentiation, focusing mainly on the ar-globin, RBC lipoxygenase and G SH PX genes. Our basic working hypothesis has been that such genes must possess some common features that respond to the erythroid cell environment: our recent results seem to have identified one component that may be involved in this process.
Cloning and characterization of genes
The GSHPX gene Some time ago, we cloned a mRNA expressed at a 50-fold higher level in mouse erythroblasts, liver and kidney compared to other cell types tested that encodes a 2 0 x l0 3Mr polypeptide and then subsequently we isolated the corresponding gene (Affara et al. 1983; Goldfarb et al. 1983 ). This has since been identified as encoding G SH PX (Chambers et al. 1986 ). One entirely novel point of interest to emerge was that the selenocysteine residue (Se-Cys) in the active site of the mouse enzyme is encoded by the 'termination codon', T G A (Chambers et al. 1986 ). More recently, this codon assignment for Se-Cys has been shown to be conserved in the human G SH PX gene and also in a bacterial seleno-enzyme, formate dehydrogenase (fdhF). This makes sense of earlier work suggesting that Se-Cys is incorporated into G SH PX co-translationally, possibly involving a specific tRNA. However, it raises intriguing questions as to how the U GA triplet is recognized as encoding Se-Cys in one mRNA but translation termination in another. One clue as to the basis for the 'mRNA context effect' for Se-Cys incorporation may be that Se-Cys is derived from serine, probably via substitution of the phosphate group in phosphoserine by selenite; thus Se-Cys-tRNA could be derived from a UGA-suppressor seryl-tRNA, which is known to exist (discussed by Chambers & Harrison, 1987) . Presumably this suppressor tRNA must recognize other sequences in certain mRNAs other than the UGA codon itself. Very recently this idea has received strong confirmation by the isolation of an Escherichia coli gene required for seleno cysteine synthesis that encodes a minor serine-tRNA species (Leinfelder et al. 1988 ).
The RBC LO X gene
Using oligonucleotides derived from the Ar-terminal amino acid sequence of the rabbit reticulocyte L O X enzyme (obtained in collaboration with Dr B. Thiele from Professor S. Rapaport's group in Berlin) to screen rabbit reticulocyte cDNA libraries, we obtained first a short cDNA recombinant whose sequence encodes the TV-terminal 30 amino acid sequence (Thiele et al. 1987a ) and later cDNAs derived from the 3' end of the LO X mRNA. By Northern blot analysis with L O X cDNAs, the RBC LO X mRNA is expressed late in erythroid differentiation and in a tissuespecific manner, not being detectable in bone marrow, heart, spleen, lung and brain cells (Thiele et al. 19876 ). This represents the first report of the cloning of any mammalian LO X mRNA, though the cloning of the human leucocyte 5-LO X mRNA has since been reported (Matsumoto et al. 1988; Dixon et al. 1988 ).
Using the LO X cDNAs to screen a rabbit genomic DNA library, a 17 kb genomic DNA recombinant has been isolated that contains the RBC LO X gene (Thiele et al. 1987b ). Using hydridization conditions of moderate stringency, the RBC LO X gene seems to be unique in the genome since the pattern of hybridization of 5' and 3' RBC LO X cDNAs to total genomic D NA digested with various restriction enzymes is fully explained by the restriction map of the 17 kb genomic DNA recombinant containing the L O X gene. This most probably means that the genes encoding the LO X isozymes of other tissues are not very closely related to the RBC LO X gene, though the various LO X proteins seem to be recognizably similar in terms of amino acid sequence. Alternatively, the various LO X s may be encoded by mRNAs generated by the splicing of alternative tissue-specific exons onto a set of common exons, as is the situation for the erythroid-specific and non-erythroid forms of PBGdeaminase (Chretien et al. 1988 ).
The transcriptional unit of the RBC LO X gene has now been defined. The site of transcription initiation has been mapped by a combination of SI nuclease mapping experiments with genomic fragments and primer extension/sequencing using the L O X mRNA and correlating the primer extension sequence with the genomic D NA sequence in the region of transcription initiation predicted by the SI mapping experiments. Furthermore, a fragment containing the first 154 nucleotide (nt) upstream of the site of transcription initiation, functions equally well as a promoter when linked to the chloramphenicol acetyltransferase (CAT) gene and tested in transient expression assays after transfection into mouse erythroleukaemia or nonerythroid cell lines. The 3' end of the gene has also been defined in the genomic recombinants by hybridization with 3'L O X cDNAs followed by sequencing of the appropriate genomic DNA region. The RBC LO X gene contains at least two introns, and the available genomic D NA recombinants contain about 2-5 kb and 6-5 kb of 5' and 3' flanking DNA, respectively.
Developmental changes in upstream transcripts from globin and non globin genes
Much evidence in the literature shows that the chromatin structure around gene control regions is often in a highly accessible conformation in cell types in which the gene is active as defined by the appearance of DNase I-hypersensitive sites (D H SS). When located 5' to the gene, such active control regions are also often the sites of minor transcripts: but whether such transcripts have a function in regulation per se or are simply diagnostic of the altered chromosome structure associated with the active gene is still far from clear.
To begin to explore such questions, we monitored the appearance of minor upstream transcripts from the mouse a-and /3-globin genes and the G SH PX gene during erythroid cell differentiation. To do this, we analysed haemopoietic stem cell lines (from Prof. T. M. Dexter, Paterson Laboratory, Manchester), committed erythroid precursor cells (CFU-Es) purified from the spleens of anaemic mice, erythroleukaemia cells at various stages of differentiation, reticulocytes and various other haemopoietic and non-haemopoietic cells. For each gene, we found that upstream transcripts occurr at distinct clusters of sites at different stages of erythropoiesis: some occur only during early erythropoiesis; some occur early and persist to the terminal stages; while others accumulate roughly in parallel with the main transcript (Frampton et al. 1987a ). This suggests that the minor transcripts that appear early in erythropoiesis may be associated with activation of the globin genes prior to onset of active transcription from the cap site.
The initiation sites for certain of these minor transcripts lie within developmen tally regulated DNase I-hypersensitive sites whose occurrence correlates with transcription of the genes modulated by trans-acting factors present in expressing versus non-expressing cell hybrids (Affara et al. 1985) ; they are also close to sequences known to be involved in globin gene regulation (for example, the TATA, CAATand CACCCT motifs). In particular, one group of /3-globin minor transcripts arise at a previously unnoticed 13 nt sequence conserved amongst adult mammalian globin genes (Frampton et al. 1987a,b) (the B box, see Fig. 2 ), which has recently been shown to be an erythroid-specific control element, by Antoniou et al. (1988) . Other groups of upstream transcripts originate from other control regions we have since identified (see below).
Regulation of the mouse «-globin gene
There has been little evidence published about the mechanisms responsible for the erythroid-specific expression of the tt-globin genes. What is known suggests that in many respects they are regulated differently from the /3-globin genes: for example, transcription of transfected human a'-globin genes in mouse erythroleukaemia cells is not greatly increased as the cells are induced to differentiate, whereas that of transfected human /3-globin genes is. We considered it worthwhile, therefore, to try to elucidate the transcriptional mechanisms responsible for the erythroid-specific expression of the mouse a'-globin gene with a view to comparing its mode of regulation with that of the much more extensively studied ^-globin genes. In particular, we decided to investigate os-control regions responsible for its erythroidspecific regulation by a combination of functional transfection assays and studies of the interactions of nuclear proteins with the a'-globin gene promoter, by comparing erythroid and non-erythroid cells (Frampton et al. 1988 ).
F unctional analysis o f the a-globin gene promoter
Progressive deletions of 4 kb of the mouse ar-globin gene 5' flanking sequence have been inserted upstream of the CAT gene under the control of a minimal 52 bp ar-globin promoter (containing only sequences from the TATA motif to the cap site) and then transfected into mouse erythroleukaemia or fibroblast (S T O ) cells. T he extent of expression of the CAT gene has been monitored mainly by transient assays, but in some cases also in stable cell lines derived by co-transfection with the selectable neomycin-resistance gene. CAT gene expression is assayed usually by enzyme activity but R N A transcripts are measured by the S I protection technique to check important conclusions. T he 52 bp ar-globin minimal promoter does not act in a tissue-specific way when compared to a minimal SV40 promoter (containing the 21 bp repeats but not the enhancer).
T he 4 kb of a'-globin 5' flanking D N A confers a 20-fold erythroid-specific increase in CAT gene expression in transient assays and this is due to at least two separate regions: a proximal region between -197 to -5 2 nt; and a distal region at about -2 kb (Fram pton et al. unpublished) . So far a tissue-specific enhancer has not been identified in the 3' flanking region of the a'-globin gene.
D N A -p ro tein interactions w ithin the a-globin promoter
The proxim al region: the CCAAT a n d CACCC motifs. T he most proximal regulatory region ( -52 to -197nt) , which confers a 4-to 5-fold increased transcription in erythroblasts compared to fibroblasts as described above, contains the previously identified CCAAT and CCA C CC regulatory elements (Fig. 2) . Three proteins binding to this region in vitro have been identified: (1) a CCAAT-binding protein; (2) a CACCC-binding protein; and (3) a protein which displaces the CCAAT-binding protein when it binds to an overlapping sequence. Although the CCAAT-binding protein is present in all tissues examined, footprint analysis with nuclear proteins from different tissues reveals two patterns: either the C CA A T- binding protein alone (in liver, spleen and erythroleukaemia cells induced to undergo erythroid maturation); or the displacement protein plus the CACCC-binding protein (in kidney, brain and undifferentiated erythroleukaemia cells).
There is increasing evidence that general transcription factors can contribute to specific gene control either as a consequence of post-translational modifications and/or due to a change in the relative concentrations of proteins which compete for binding to the same sequence. Experiments are in progress to try to elucidate how the combination of the three proteins (and any others not yet detected) contribute to the erythroid-specificity of this region of the ar-globin promoter.
The a-globin GATAAG motif. Footprint and gel-shift analysis of the erythroidspecific regulatory element between -129 and -197 nt with mouse and human nuclear extracts revealed an erythroid-specific protein which binds to a GATAAG motif. The factor is found only in erythroid cells and is conserved between species: it is found in mouse erythroleukaemia cells, chicken erythrocytes and human erythroid cell lines K562 and KM O E; but not in mouse brain, kidney and spleen or HeLa cells -mouse liver contains a protein binding to the GATAAG region but it seems to be different from the factor present in erythroid cells (Plumb et al. 1989 ). In all cases specificity of DNA-protein interactions was confirmed by competition experiments with specific oligonucleotides.
The role of the GATAAG motif in erythroid cell-specific gene expression

Globin genes
A GATAAG motif is also present about 200 nt upstream of the mouse /3-major globin gene ( Fig. 2) and it also is footprinted by the same factor (Plumb et al. 1989 ). Since both the a-and /3-globin GATAAG regions lie within erythroid-specific DNase Ihypersensitive sites in vivo, both globin GATAAG sequences probably bind to the GATAAG-binding factor in vivo in an erythroid-specific manner. GATAAG motifs are also present upstream of certain other globin genes: some of these have been shown to bind an erythroid-specific factor, for example the chicken a-pi, <*-D, and ¡3-rho globin genes, as reported by Kemper et al. (1987) ; and we have shown that this chicken factor also binds to the mouse a-and /3-GATAAG elements (Plumb et al. 1989) .
The roles the GATAAG regions of the a-and /3-globin genes play in regulating their erythroid-specific transcription have also been investigated. It may be of significance that the a-and /3-globin GATAAG regions are sites of erythroid-specific upstream transcripts (Frampton et al. 1987a) (Fig. 2) . Deletion of a 60nt region of the a-globin promoter containing the GATAAG element from a long promoter fragment (from the cap site to -700 nt) linked to the CAT gene reduces the promoter activity 2-fold in transient transfection assays with erythroblasts but not with fibroblasts. Consistent with this, linking one or two copies of the deleted GATAAG fragment to the minimal 52 nt Cf-globin promoter increases its promoter activity in erythroblasts 2-to 3-fold but not in fibroblasts: intriguingly, a single copy of the same GATAAG region inserted in the reverse orientation gives a 10-fold erythroid-specific increase. Similar experiments with the /3-globin promoter show that a single copy of a 60 nt fragment containing the ¡3-globin GATAAG region also gives an erythroid-specific increase in promoter activity, but in this case the effect is large (12 fold) irrespective of orientation (unpublished data). The reasons for the different functional activities of these short a-or /3-globin GATAAG-containing fragments are presently unclear: it is still possible that nearby sequences modulate their effects; alternatively, the a-and ¡3-GATAAG motifs may have different affinities for the available factor or they could function at different stages of differentiation. Since it is not feasible for technical reasons to perform transient assays in erythroleukaemia cells induced to undergo differentiation, the function of the a-and /3-globin GATAAG regions are being tested in erythroleukaemia cells stably transfected with the appropriate constructs.
GATAAG-like motifs are also present upstream of several other globin genes, in the 3' enhancer of the chicken adult /3-globin gene and in a putative enhancer in the erythroid-specific DNase I-hypersensitive site in the second intron of the mouse y8maior-globin gene. Recent results using gel retardation assays have shown that the GATAAG motif in the chicken /3-globin 3' enhancer interacts strongly with the 5' globin GATAAG-binding protein (Plumb et al. 1989 ): this suggests that the GATAAG-binding factor may interact cooperatively with both 5' and 3' globin control regions.
Other genes
Both the G SH PX gene promoter and the erythroid-specific promoter of the gene encoding the haem pathway enzyme, PBG-deaminase, contain exact GATAAG motifs, and the latter binds in vitro to the mouse and human globin gene GATAAGbinding factors (Plumb et al. 1989 ). Footprinting of the GATAAG motif in the G SH P X promoter has not yet been attempted, but it seems to be of some significance since it is the only sequence upstream of the coding region, apart from the TATA-like motif and one other sequence, that is conserved between the mouse and human genes. Although it does not contain an exact GATAAG sequence, the LO X gene promoter could still bind the GATAAG-binding factor since the consensus sequence for the GATAAG-binding factor is not yet known.
The major thrust of our future work in this area is to purify the GATAAG-binding protein by affinity chromatography and other means in order ultimately to clone the gene that encodes it so as to be able to elucidate further its putative role in erythroid cell-specific gene expression and how it functions in relation to other control regions. In the longer term, it will be worthwhile to investigate the function of the GATAAGbinding protein in relation to other transcription factors in in vitro transcription systems or in permeabilized cells.
Regulation of non-globin genes
The GSHPX gene The G SH PX mRNA is expressed at high levels in erythroid cells, kidney and liver compared to the low basal level in other cell types tested (Affara et al. 1983 (Affara et al. , 1985 . This control seems to be primarily at the transcription level since the tissue-specific changes in mRNA levels are reflected in similar changes in the level of the G SH PX primary transcript, as determined using total cellular RNA in SI protection experiments with an intron-specific probe (I. Chambers & P. R. Harrison, unpublished results).
In terms of established transcriptional control signals, the 5' flanking region of the mouse G SH P X gene has a TATA-like box but no CAAT-box and is G + C-rich, containing several potential binding sites for the transcription factor, Sp i (Chambers et al. 1986 ). There are also tissue-specific anti-sense transcripts from the G SH PX promoter region (J. Frampton, unpublished data) and the promoter region is a site of DNase I hypersensitivity in the chromatin of both high-and low-expressing tissues (Affara et al. 1985) . In these respects, it has characteristics of other 'housekeeping' genes that are expressed in all cells, though often more highly in some than others. The 5' flanking region also contains the species-conserved GATAAG motif noted above. The 3' flanking region contains a perfect SV40 core enhancer sequence flanked by potential S p i-binding consensus sites. To test whether the G SH PX promoter itself is responsible for the elevated expression of the gene in erythroid cells, 680 bp of 5' flanking DNA sequence was linked to the CAT gene and tested for promoter function in transient assays when transfected into erythroleukaemia cells or fibroblasts. However, the G SH PX promoter functioned equally well in both cell types when compared to the minimal SV40 promoter.
Our earlier experiments showed that the G SH P X gene possesses tissue-specific D H SS s in the 3' flanking region in erythroblasts (Affara et al. 1985) . Subsequent work has mapped these D H SS more accurately and showed that other high expressing tissues like liver and kidney also have a broad 3' D H SS (2-2-2-6kb from the polyadenylation site) like erythroid cells; but erythroid cells possess other 3' D H SS in addition, about 200-300 nt and 700-800nt 3' to the polyadenylation site (I. Chambers and P. R .H ., unpublished data) . Unfortunately, these 3' D H SS lie outside the fragments of the G SH P X gene present in the genomic recombinants available, but once 3' overlapping genomic fragments have been isolated the 3' flanking D N A in the regions of the tissue-specific D H SS will be tested for enhancer activity in functional transfection assays and any tissue-specific proteins that interact with functionally important regions identified.
The RBC LO X gene
Sequencing of the immediate upstream region has revealed a TATA-like motif at -30 nt but no CAAT nor GATAAG motifs. To locate possible control regions, two approaches are being adopted. The 6-5 kb 3' flanking region of the LO X gene has also been cloned 3 ' to the LO X promoter/CAT gene construct and introduced into erythroid and fibroblast cell lines but no 3 ' enhancer has yet been detected. It is anticipated that these ongoing experiments will reveal interesting information about the tissue-specific regulation of the RBC LO X gene vis-à-vis the globin, G SH P X and PBG-deaminase genes.
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